GIP and type 2 diabetes mellitus: In overweight or obese individuals with T2DM, GLP-1RAs such as semaglutide or dual GIP inhibitors like tirzepatide are recommended due to their effectiveness in weight control as well as their glycemic and cardiometabolic benefits [43].